Failure of adipocyte differentiation causes type II diabetes mellitus?
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, it has been suggested that the inhibition of new adipose cell formation is a trigger for the development of insulin resistance (IR), principally in the subcutaneous (sc) fat depots (i.e., abdominal and tight fat).”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [4]
In the citing paper
“This provocative concept (“expandability hypothesis”) justifies in part the seeming paradox of an increased risk of IR under circumstances when body fat is both reducing (i.e., lipodystrophy) and expanding (i.e., adiposity) [4,5].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [4]
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara, T., Horikoshi, H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1235 · Cited by 995
Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
Gavrilova, O., Marcus-Samuels, B., Graham, D., Kim, J. K., Shulman, G. I., Castle, A. L., Vinson, C., Eckhaus, M., & Reitman, M. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7901 · Cited by 676
Fatty acids, lipotoxicity and insulin secretion
McGarry, J. D., & Dobbins, R. L. (1999) · Diabetologia · doi:10.1007/s001250051130 · Cited by 552
Regulation of fatty acid homeostasis in cells: Novel role of leptin
Unger, R. H., Zhou, Y.-T., & Orci, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2327 · Cited by 435
Effect of early nutrition on the development of rat epididymal fat pads: cellularity and metabolism
Knittle, J. L., & Hirsch, J. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105894 · Cited by 393
Paolisso, G., Tataranni, P. A., Foley, J. E., Bogardus, C., Howard, B. V., & Ravussin, E. (1995) · Diabetologia · doi:10.1007/bf00422371 · Cited by 367
In vivo modulation of Hmgic reduces obesity
Anand, A., & Chada, K. (2000) · Nature Genetics · doi:10.1038/74207 · Cited by 223
The effect of diet on thermogenesis in acquired lipodystrophy
Robbins, D. C., Danforth, E., Horton, E. S., Burse, R. L., Goldman, R. F., & Sims, E. A. H. (1979) · Metabolism · doi:10.1016/0026-0495(79)90090-8 · Cited by 45
Self-citationThe effects of short-term overfeeding on adipocyte metabolism in pima Indians
Kashiwagi, A., Mott, D. M., Bogardus, C., Lillioja, S., Reaven, G. M., & Foley, J. E. (1985) · Metabolism · doi:10.1016/0026-0495(85)90226-4 · Cited by 44
Cited by
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms
The International SNP Map Working Group, Laboratories:, C. S. H., Sachidanandam, R., Weissman, D., Schmidt, S. C., Kakol, J. M., Stein, L. D., National Center for Biotechnology Information:, Marth, G., Sherry, S., et al. (2001) · Nature · doi:10.1038/35057149 · Cited by 2,977
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662
Insulin and insulin resistance:
Sowers, J. R., & Frohlich, E. D. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00128-7 · Cited by 1,518
Blocks of Limited Haplotype Diversity Revealed by High-Resolution Scanning of Human Chromosome 21
Patil, N., Berno, A. J., Hinds, D. A., Barrett, W. A., Doshi, J. M., Hacker, C. R., Kautzer, C. R., Lee, D. H., Marjoribanks, C., McDonough, D. P., et al. (2001) · Science · doi:10.1126/science.1065573 · Cited by 1,145
Disordered lipid metabolism and the pathogenesis of insulin resistance.
Savage, D. B., Petersen, K. F., & Shulman, G. I. (2007) · Physiological Reviews · doi:10.1152/physrev.00024.2006 · Cited by 1,107
“The simple explanation is that in obese states, energy intake exceeds the storage capacity of adipose tissue leading to energy “overflow” to ectopic sites (25, 104).”
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,073
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Lee, M.-J., Wu, Y., & Fried, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.001 · Cited by 812
The science of obesity management: an endocrine society scientific statement
Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00253 · Cited by 812
Reduced Adipose Tissue Oxygenation in Human Obesity
Pasarica, M., Sereda, O. R., Redman, L. M., Albarado, D. C., Hymel, D. T., Roan, L. E., Rood, J. C., Burk, D. H., & Smith, S. R. (2009) · Diabetes · doi:10.2337/db08-1098 · Cited by 786
“The failure of AT to adequately proliferate and/or differentiate to sequester lipids away from liver, skeletal muscle, and the pancreatic -cell has been proposed as a precursor to type 2 diabetes, broadening the number of potential mechanisms linking obesity to insulin resistance (2).”
BackgroundAdipose tissue as a buffer for daily lipid flux
Frayn, K. (2002) · Diabetologia · doi:10.1007/s00125-002-0873-y · Cited by 752
“Indeed, it has been proposed that an inability to differentiate new adipocytes as required for storage of excess energy underlies the development of Type II diabetes [77].”
BackgroundRole of Body Fat Distribution and the Metabolic Complications of Obesity
Jensen, M. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1585 · Cited by 687
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664
“The sequence of events by which the inability to store fat in adipose tissue leads to ectopic accumulation of triglycerides in muscle and liver, hepatic and muscle insulin resistance, glucose intolerance, and overt diabetes has been referred to as the overflow hypothesis (248).”
BackgroundThe Origins and Drivers of Insulin Resistance
Johnson, A. M. F., & Olefsky, J. M. (2013) · Cell · doi:10.1016/j.cell.2013.01.041 · Cited by 643
EPIC-InterAct Consortium, Lotta, L. A., Cambridge FPLD1 Consortium, Gulati, P., Day, F. R., Payne, F., Ongen, H., van de Bunt, M., Gaulton, K. J., Eicher, J. D., et al. (2017) · Nature Genetics · doi:10.1038/ng.3714 · Cited by 585
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
Contribution of adipogenesis to healthy adipose tissue expansion in obesity
Vishvanath, L., & Gupta, R. K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129191 · Cited by 558
“Such studies support a “limited expandability hypothesis,” whereby the inability of WAT depots to adequately expand to meet the energy storage demands results in adipose tissue dysfunction, ectopic lipid deposition, and insulin resistance (53, 54).”
BackgroundCauses, consequences, and treatment of metabolically unhealthy fat distribution
Stefan, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30110-8 · Cited by 541
Biology of upper-body and lower-body adipose tissue—link to whole-body phenotypes.
Karpe, F., & Pinnick, K. E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.185 · Cited by 543
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 530
Lynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., Balk, S. P., O’Shea, D., O’Farrelly, C., & Exley, M. A. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.016 · Cited by 512
“One hypothesis is that adipocytes are dysfunctional when filled to capacity ( 3 mg lipid per cell) (Danforth, 2000), causing ‘‘overflow’’ of lipids to muscle and liver (Gregor and Hotamisligil, 2007) and leading to overproduction of glucose and high fatty-acid levels, which can activate the kinases…”
BackgroundLarson-Meyer, D. E., Heilbronn, L. K., Redman, L. M., Newcomer, B. R., Frisard, M. I., Anton, S., Smith, S. R., Alfonso, A., Ravussin, E., & the Pennington CALERIE Team (2006) · Diabetes Care · doi:10.2337/dc05-2565 · Cited by 504
“These findings support the hypothesis that inadequate subcutaneous adipose stores result in lipid overflow into visceral fat and other nonadipose tissues (39).”
BackgroundMetabolic syndrome: Definition, pathophysiology, and mechanisms
Miranda, P. J., DeFronzo, R. A., Califf, R. M., & Guyton, J. R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.013 · Cited by 479
Borlaug, B. A., Jensen, M. D., Kitzman, D. W., Lam, C. S. P., Obokata, M., & Rider, O. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac120 · Cited by 450
Bays, H. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.038 · Cited by 431
“Conversely, liposuction of SAT may not improve CVD risk factors such as hyperglycemia, high blood pressure, and dyslipidemia (142).”
BackgroundInfluentialChlorinated Persistent Organic Pollutants, Obesity, and Type 2 Diabetes
Lee, D.-H., Porta, M., Jacobs, D. R., & Vandenberg, L. N. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1084 · Cited by 420
“However, when there are inhibitors impairing adipocyte proliferation and/or differentiation, excess energy mainly leads to a serious enlargement of pre-existing adipocytes (93).”
BackgroundMcLaughlin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., Reaven, G. M., & Cushman, S. W. (2007) · Diabetologia · doi:10.1007/s00125-007-0708-y · Cited by 364
“small adipose cells, suggesting that precursor cells accumulate enough triacylglycerol to be designated adipose cells by floatation or relative size but cannot further function in the triacylglycerol storage process, consistent with observations that insulin-resistant individuals have relatively greater quantities of…”
BackgroundTranscriptional Regulation of Adipogenesis
de Sá, P. M., Richard, A. J., Hang, H., & Stephens, J. M. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c160022 · Cited by 360
“As proposed by Danforth over fifteen years ago, a failure in adipocyte differentiation can cause type 2 diabetes (64), and this theory is generally recognized by experts as a dogma since it is supported by multiple independent lines of investigation in adipocyte biology.”
Lee, E. K., Lee, M. J., Abdelmohsen, K., Kim, W., Kim, M. M., Srikantan, S., Martindale, J. L., Hutchison, E. R., Kim, H. H., Marasa, B. S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.00894-10 · Cited by 360
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
“Danforth E Jr.: Failure of adipocyte differentiation causes type II diabetes mellitus?”
BackgroundFrom excess adiposity to insulin resistance: The role of free fatty acids
Capurso, C., & Capurso, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.003 · Cited by 337
Cellular senescence: at the nexus between ageing and diabetes
Palmer, A. K., Gustafson, B., Kirkland, J. L., & Smith, U. (2019) · Diabetologia · doi:10.1007/s00125-019-4934-x · Cited by 337
Sarjeant, K., & Stephens, J. M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008417 · Cited by 328
Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C., & Sharma, A. M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1699 · Cited by 322
Aging and adipose tissue: potential interventions for diabetes and regenerative medicine
Palmer, A. K., & Kirkland, J. L. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.02.013 · Cited by 321
“Decline in adipogenic potential has been postulated to drive insulin resistance by limiting the ability of adipose tissue to expand in the face of excess nutrients (Danforth, 2000).”
TOS Obesity as a Disease Writing Group, Allison, D. B., Downey, M., Atkinson, R. L., Billington, C. J., Bray, G. A., Eckel, R. H., Finkelstein, E. A., Jensen, M. D., & Tremblay, A. (2008) · Obesity · doi:10.1038/oby.2008.231 · Cited by 321
Heilbronn, L. K., Rood, J., Janderova, L., Albu, J. B., Kelley, D. E., Ravussin, E., & Smith, S. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031410 · Cited by 307
Freedland, E. S. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-12 · Cited by 298
“It has been proposed that an inability to differentiate new adipocytes to accommodate and store excess energy, underlies the development of type 2 diabetes [72,73].”
Human Mesenchymal Stem Cells as an in Vitro Model for Human Adipogenesis
Janderová, L., McNeil, M., Murrell, A. N., Mynatt, R. L., & Smith, S. R. (2003) · Obesity Research · doi:10.1038/oby.2003.11 · Cited by 295
Flachs, P., Rossmeisl, M., Bryhn, M., & Kopecky, J. (2009) · Clinical Science · doi:10.1042/cs20070456 · Cited by 286
Variation in Type 2 Diabetes-Related Traits in Mouse Strains Susceptible to Diet-Induced Obesity
Rossmeisl, M., Rim, J. S., Koza, R. A., & Kozak, L. P. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1958 · Cited by 283
“It was recently hypothesized that a higher capacity to store excess calories in adipose tissue prevents the development of insulin resistance and diabetes (26).”
BackgroundAngiotensin Blockade Prevents Type 2 Diabetes by Formation of Fat Cells
Sharma, A. M., Janke, J., Gorzelniak, K., Engeli, S., & Luft, F. C. (2002) · Hypertension · doi:10.1161/01.hyp.0000036448.44066.53 · Cited by 283
Larsen, T. M., Toubro, S., & Astrup, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802223 · Cited by 282
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’
Lundgren, M., Svensson, M., Lindmark, S., Renström, F., Ruge, T., & Eriksson, J. W. (2007) · Diabetologia · doi:10.1007/s00125-006-0572-1 · Cited by 277
“muscle and liver [9], which in turn contribute to insulin resistance [10].”
BackgroundThe renin‐angiotensin system: a link between obesity, inflammation and insulin resistance
Kalupahana, N. S., & Moustaid‐Moussa, N. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00942.x · Cited by 276
“Because a reduced adipogenic capacity is linked to adipose tissue inflammation and systemic insulin resistance in obesity (85), it is important to investigate the effects of adipose RAS on both adipogenesis and lipogenesis, and conversely on both adipose hyperplasia and hypertrophy.”
BackgroundBody composition phenotypes in pathways to obesity and the metabolic syndrome
Dulloo, A. G., Jacquet, J., Solinas, G., Montani, J.-P., & Schutz, Y. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.234 · Cited by 271
The renin-angiotensin-aldosterone system, glucose metabolism and diabetes
Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267
The origin of intermuscular adipose tissue and its pathophysiological implications
Vettor, R., Milan, G., Franzin, C., Sanna, M., De Coppi, P., Rizzuto, R., & Federspil, G. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00229.2009 · Cited by 261
Adipose cell size: importance in health and disease
Stenkula, K. G., & Erlanson-Albertsson, C. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00257.2017 · Cited by 245
Sopasakis, V. R., Sandqvist, M., Gustafson, B., Hammarstedt, A., Schmelz, M., Yang, X., Jansson, P., & Smith, U. (2004) · Obesity Research · doi:10.1038/oby.2004.51 · Cited by 243
The autocrine and paracrine roles of adipokines
Karastergiou, K., & Mohamed-Ali, V. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.11.011 · Cited by 233
“It has been proposed that inhibition of adipogenesis, the process of conversion of pre-adipocytes to lipid-laden adipocytes, in subcutaneous depots, in the face of a continuing ability to differentiate visceral adipocytes normally, leads to type 2 diabetes (Danforth, 2000).”
BackgroundLotta, L. A., Wittemans, L. B. L., Zuber, V., Stewart, I. D., Sharp, S. J., Luan, J., Day, F. R., Li, C., Bowker, N., Cai, L., et al. (2018) · JAMA · doi:10.1001/jama.2018.19329 · Cited by 229
Celis, J. E., Moreira, J. M. A., Cabezón, T., Gromov, P., Friis, E., Rank, F., & Gromova, I. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500030-mcp200 · Cited by 215
Lipodystrophy: metabolic insights from a rare disorder
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0272 · Cited by 215
Larson‐Meyer, D. E., Newcomer, B. R., Heilbronn, L. K., Volaufova, J., Smith, S. R., Alfonso, A. J., Lefevre, M., Rood, J. C., Williamson, D. A., Ravussin, E., et al. (2008) · Obesity · doi:10.1038/oby.2008.201 · Cited by 215
White adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
Subcutaneous adipocyte size and body fat distribution
Tchoukalova, Y. D., Koutsari, C., Karpyak, M. V., Votruba, S. B., Wendland, E., & Jensen, M. D. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.56 · Cited by 204
“The finding that both abdominal (visceral and subcutaneous) and leg fat masses are related to abdominal adipocyte size in opposite directions is partially consistent with the hypothesis that impaired capacity of fat storage in the subcutaneous adipose tissue leads to compensatory storage of excess fat in visceral and…”
Demerath, E. W., Reed, D., Rogers, N., Sun, S. S., Lee, M., Choh, A. C., Couch, W., Czerwinski, S. A., Chumlea, W. C., Siervogel, R. M., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26546 · Cited by 203
Adipose tissue distribution is different in type 2 diabetes
Gallagher, D., Kelley, D. E., Yim, J.-E., Spence, N., Albu, J., Boxt, L., Pi-Sunyer, F. X., & Heshka, S. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26955 · Cited by 201
Disease-associated metabolic pathways affected by heavy metals and metalloid
Haidar, Z., Fatema, K., Shoily, S. S., & Sajib, A. A. (2023) · Toxicology Reports · doi:10.1016/j.toxrep.2023.04.010 · Cited by 199
“Similar to chromium, vanadium compounds can enhance insulin response in T2D [166].”
BackgroundInfluentialSPARC: a key player in the pathologies associated with obesity and diabetes
Kos, K., & Wilding, J. P. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.18 · Cited by 192
A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
Smith, S. R., Bai, F., Charbonneau, C., Janderová, L., & Argyropoulos, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1611 · Cited by 188
“Indeed, failure of adipocyte differentiation has been proposed as a cause of type 2 diabetes (15), possibly through an ectopic overload of fatty acids and lipotoxicity of nonadipose tissues (16).”
BackgroundPinnick, K. E., Nicholson, G., Manolopoulos, K. N., McQuaid, S. E., Valet, P., Frayn, K. N., Denton, N., Min, J. L., Zondervan, K. T., Fleckner, J., et al. (2014) · Diabetes · doi:10.2337/db14-0385 · Cited by 186
“The cellular or mechanistic basis for these pathways may involve a reduced capacity to recruit and renew adipocytes thus limiting AT expandability (24), induction of innate immune mechanisms, or the activation of cellular stress pathways (25).”
BackgroundForkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure
Nakae, J., Cao, Y., Oki, M., Orba, Y., Sawa, H., Kiyonari, H., Iskandar, K., Suga, K., Lombes, M., & Hayashi, Y. (2008) · Diabetes · doi:10.2337/db07-0698 · Cited by 187
“enlargement of the existing adipocytes and also a “spillover” and ectopic accumulation of lipids in other tissues, such as muscle and liver (47).”
BackgroundStefan, N., Machicao, F., Staiger, H., Machann, J., Schick, F., Tschritter, O., Spieth, C., Weigert, C., Fritsche, A., Stumvoll, M., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1948-3 · Cited by 186
“Ectopic fat disposition, particularly in the liver, is considered a major factor preceding insulin resistance and type 2 diabetes [25, 26].”
BackgroundTargeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183
“These hypertrophic adipocytes are less sensitive to the action of insulin and have impaired lipid-buffering capacity (139).”
BackgroundThe Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensitivity
FLACHS, P., ROSSMEISL, M., & KOPECKY, J. (2014) · Physiological Research · doi:10.33549/physiolres.932715 · Cited by 183
What lipodystrophies teach us about the metabolic syndrome
Mann, J. P., & Savage, D. B. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129190 · Cited by 179
Medrikova, D., Jilkova, Z. M., Bardova, K., Janovska, P., Rossmeisl, M., & Kopecky, J. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.87 · Cited by 178
PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1
Chui, P. C., Guan, H.-P., Lehrke, M., & Lazar, M. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24130 · Cited by 178
“TZDs promote fatty acid uptake and triglyceride storage in adipose tissue to reduce the level of plasma FFAs and to promote the flux of fatty acids away from the liver and muscle; high levels of plasma FFAs and of fatty acid in liver and muscle correlate with insulin resistance (78, 79).”
The Emerging Functions of UCP2 in Health, Disease, and Therapeutics
Mattiasson, G., & Sullivan, P. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1 · Cited by 177
“In the genetically obese Zucker fatty rat, diabetes develops at about 10–12 wk of life, and this is associated with a marked increase in islet triglyceride content and FA-CoA levels which eventually lead to (cid:1) -cell dysfunction and apoptosis.”
Bodyweight Changes Associated with Antihyperglycaemic Agents in Type 2 Diabetes Mellitus
Hermansen, K., & Mortensen, L. S. (2007) · Drug Safety · doi:10.2165/00002018-200730120-00005 · Cited by 174
Distribution of body fat and risk of coronary heart disease in men and women
Canoy, D. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328313133a · Cited by 171
Evidence of impaired adipogenesis in insulin resistance
Yang, X., Jansson, P.-A., Nagaev, I., Jack, M. M., Carvalho, E., Sunnerhagen, K. S., Cam, M. C., Cushman, S. W., & Smith, U. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.152 · Cited by 170
Decreased Expression of Adipogenic Genes in Obese Subjects with Type 2 Diabetes
Dubois, S. G., Heilbronn, L. K., Smith, S. R., Albu, J. B., Kelley, D. E., Ravussin, E., & The Look AHEAD Adipose Research Group (2006) · Obesity · doi:10.1038/oby.2006.178 · Cited by 168
Kingston, R. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00006 · Cited by 166
Shao, M., Vishvanath, L., Busbuso, N. C., Hepler, C., Shan, B., Sharma, A. X., Chen, S., Yu, X., An, Y. A., Zhu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03196-x · Cited by 161
Louwen, F., Ritter, A., Kreis, N. N., & Yuan, J. (2018) · Obesity Reviews · doi:10.1111/obr.12679 · Cited by 160
Proteomic Analysis of Primary Cultures of Human Adipose-derived Stem Cells
DeLany, J. P., Floyd, Z. E., Zvonic, S., Smith, A., Gravois, A., Reiners, E., Wu, X., Kilroy, G., Lefevre, M., & Gimble, J. M. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400198-mcp200 · Cited by 153
Genomic insights into the causes of type 2 diabetes
Langenberg, C., & Lotta, L. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31132-2 · Cited by 149
Zhang, T., Chen, J., Tang, X., Luo, Q., Xu, D., & Yu, B. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-1170-9 · Cited by 179
Furuhashi, M., Ura, N., Takizawa, H., Yoshida, D., Moniwa, N., Murakami, H., Higashiura, K., & Shimamoto, K. (2004) · Journal of Hypertension · doi:10.1097/00004872-200410000-00021 · Cited by 171
Obesity, hypertension and insulin resistance
Sharma, A. M., & Chetty, V. T. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0175-1 · Cited by 176
“However, the failure to produce sufficient fat cells has been recognised as contributing to the development of diabetes [36].”
BackgroundKloock, S., Ziegler, C. G., & Dischinger, U. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108549 · Cited by 199
Miljkovic, I., Kuipers, A. L., Cauley, J. A., Prasad, T., Lee, C. G., Ensrud, K. E., Cawthon, P. M., Hoffman, A. R., Dam, T.-T., Gordon, C. L., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv027 · Cited by 144
Caprio, S., Perry, R., & Kursawe, R. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.051 · Cited by 142
Adipocyte morphology and implications for metabolic derangements in acquired obesity
Heinonen, S., Saarinen, L., Naukkarinen, J., Rodríguez, A., Frühbeck, G., Hakkarainen, A., Lundbom, J., Lundbom, N. M. I., Vuolteenaho, K., Moilanen, E., et al. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.31 · Cited by 163
Kopecky, J., Rossmeisl, M., Flachs, P., Kuda, O., Brauner, P., Jilkova, Z., Stankova, B., Tvrzicka, E., & Bryhn, M. (2009) · Proceedings of the Nutrition Society · doi:10.1017/s0029665109990231 · Cited by 137
Committed subcutaneous preadipocytes are reduced in human obesity
Tchoukalova, Y. D., Koutsari, C., & Jensen, M. D. (2006) · Diabetologia · doi:10.1007/s00125-006-0496-9 · Cited by 149
“Such an interpretation is in harmony with the hypothesis that the inability of subcutaneous adipose tissue to expand in the face of excess fat storage drives the accumulation of fat in the visceral depots or in ectopic sites [17].”
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Villa, J., & Pratley, R. E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0189-8 · Cited by 139
“Danforth [31] has proposed that the inability to differentiate sufficient new subcutaneous adipocytes in response to chronic excess energy intake may account for the metabolic dysfunction observed in some obese individuals.”
BackgroundKoska, J., Stefan, N., Permana, P. A., Weyer, C., Sonoda, M., Bogardus, C., Smith, S. R., Joanisse, D. R., Funahashi, T., Krakoff, J., et al. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.2.295 · Cited by 129
“Age (y)(2) 25 (21, 34)(3) 27 (22, 34) 24 (20, 32) BMI (kg/m(2))(2) 36 4(4) 35 (4) 36 (5) Body fat (%)(2) 35 (5) 32 (4) 40 (4)(5) Mean adipocyte diameter ( m)(6) 68 (7) 66 (7) 73 (6)(7) Subcutaneous adipose tissue (cm(2))(8) 578 (457, 693) 524 (411, 689) 634 (520, 713) Visceral adipose tissue (cm(2))(8) 120 (42) 129 (4…”
BackgroundInfluentialKursawe, R., Eszlinger, M., Narayan, D., Liu, T., Bazuine, M., Cali, A. M. G., D'Adamo, E., Shaw, M., Pierpont, B., Shulman, G. I., et al. (2010) · Diabetes · doi:10.2337/db10-0113 · Cited by 129
“Danforth (1) and Shulman (2) raised the hypothesis that inadequate subcutaneous fat stores result in lipid overflow into visceral fat and other nonadipose tissues, which was elegantly explored by Ravussin and Smith (3).”
BackgroundEvidence for the intra-uterine programming of adiposity in later life
Fall, C. H. D. (2011) · Annals of Human Biology · doi:10.3109/03014460.2011.592513 · Cited by 122
“Inadequate foetal nutrition is thought to result in reduced numbers of adipocytes and/or a reduced storage capacity of adipocytes, which may favour visceral fat deposition in the presence of a positive energy balance post-natally (Danforth 2000).”
BackgroundMurdolo, G., Piroddi, M., Luchetti, F., Tortoioli, C., Canonico, B., Zerbinati, C., Galli, F., & Iuliano, L. (2012) · Biochimie · doi:10.1016/j.biochi.2012.12.014 · Cited by 141
Lumish, H. S., O'Reilly, M. E., & Reilly, M. P. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313154 · Cited by 139
Adipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 229
Early-life origins of metabolic dysfunction: role of the adipocyte
Mühlhäusler, B. S., & Smith, S. R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.006 · Cited by 137
Metadata
- Authors
- Danforth, E.
- Affiliations
- University of Vermont (US)
- Corresponding author
- Danforth, Elliot
- Venue
- Nature Genetics
- Published
- 2000-09-01
- Volume
- 26
- Issue
- 1
- Pages
- 13-13
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1877352094
- Cited by
- 487
- References
- 10
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 10 · 2023: 14 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 18 · 2018: 30 · 2017: 25 · 2016: 27 · 2015: 20 · 2014: 21 · 2013: 32 · 2012: 27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adipogenesis, type 2 diabetes, adipose tissue, insulin resistance
- MeSH terms
- Adipose Tissue, Animals, Cell Differentiation, Diabetes Mellitus, Type 2, Humans, Rats, Zucker, Adipocytes, Mice, Knockout, Polymorphism, Single Nucleotide, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.